Photo by Pixabay on Pexels.com Photo by Pixabay on Pexels.com Photo by Pixabay on Pexels.com
One of the most frustrating things about medical research is drug resistance. You know the old story- clever people spend years developing a new antibiotic, only for the target to become resistant in a few years. Back to life, back to reality as the old Soul to Soul song would have it. The way bacteria do it is rather clever and we include a detailed link here* for those who are interested. Basically, if you’re a bacterium resistance is all about changing your peripheral bits while keeping your core functions stable.
It’s a moot point whether viruses are alive or not; but they certainly obey Darwinian laws of natural selection, building resistance to hostile drugs. One such is herpes, which can do immense damage to us, as sufferers will know. Now a team at Lund University led by Professor Alex Evilevitch is trying a new approach-target their attack on the core functions, which by definition the virus can’t change. Here we have a report from Mariella Attard of Forbes which outlines the work.*
We at LSS always like it when someone tries to solve an old problem in a new way. Maybe it’s applying the wonders of AI to drug databases and throwing up a new antibiotic. Maybe it’s suddenly realising that birds are dinosaurs, they’ve been living alongside us for millions of years. You always get something new when you look at facts from a different perspective.
We thank Mr Peter Seymour of Hertfordshire for this story If you want to help with the problem of drug resistance visit the website of antibiotic research uk*
here’s how bacteria resist
here’s the Forbes article
#drugresistance #herpes #virus #bacteria